Kewaunee Scientific Co. (NASDAQ:KEQU) Shares Bought by American Century Companies Inc.

American Century Companies Inc. grew its holdings in Kewaunee Scientific Co. (NASDAQ:KEQU) by 18.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 34,293 shares of the technology company’s stock after purchasing an additional 5,221 shares during the quarter. American Century Companies Inc. owned approximately 1.19% of Kewaunee Scientific worth $2,122,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Truffle Hound Capital LLC acquired a new position in Kewaunee Scientific in the fourth quarter valued at $619,000. Morgan Dempsey Capital Management LLC acquired a new position in Kewaunee Scientific during the fourth quarter valued at approximately $106,000. Minerva Advisors LLC grew its stake in Kewaunee Scientific by 4.1% during the fourth quarter. Minerva Advisors LLC now owns 109,493 shares of the technology company’s stock worth $6,668,000 after buying an additional 4,311 shares during the period. IFP Advisors Inc acquired a new stake in shares of Kewaunee Scientific in the fourth quarter worth $36,000. Finally, Janney Montgomery Scott LLC purchased a new position in shares of Kewaunee Scientific in the 4th quarter valued at $338,000. 32.69% of the stock is owned by hedge funds and other institutional investors.

Kewaunee Scientific Stock Down 3.1 %

Shares of Kewaunee Scientific stock opened at $34.94 on Wednesday. The business has a 50-day moving average price of $51.88 and a 200 day moving average price of $47.38. Kewaunee Scientific Co. has a fifty-two week low of $30.82 and a fifty-two week high of $71.33. The firm has a market cap of $99.75 million, a P/E ratio of 5.54 and a beta of 0.59. The company has a quick ratio of 2.13, a current ratio of 2.64 and a debt-to-equity ratio of 0.45.

Kewaunee Scientific (NASDAQ:KEQU) last posted its earnings results on Wednesday, March 12th. The technology company reported $1.09 EPS for the quarter. The company had revenue of $67.17 million during the quarter. Kewaunee Scientific had a return on equity of 25.83% and a net margin of 9.39%.

Analyst Ratings Changes

Separately, StockNews.com lowered Kewaunee Scientific from a “buy” rating to a “hold” rating in a research note on Friday, March 14th.

Insider Buying and Selling at Kewaunee Scientific

In other news, CEO Thomas David Hull III sold 1,368 shares of the company’s stock in a transaction on Friday, January 10th. The stock was sold at an average price of $60.08, for a total transaction of $82,189.44. Following the completion of the sale, the chief executive officer now directly owns 41,129 shares of the company’s stock, valued at $2,471,030.32. This represents a 3.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Keith M. Gehl acquired 1,000 shares of the stock in a transaction on Friday, April 4th. The shares were purchased at an average price of $35.00 per share, for a total transaction of $35,000.00. Following the completion of the transaction, the director now owns 18,500 shares in the company, valued at approximately $647,500. This represents a 5.71 % increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders have sold 8,838 shares of company stock valued at $423,936. Company insiders own 14.20% of the company’s stock.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.